Hematoxylin structure
|
Common Name | Hematoxylin | ||
|---|---|---|---|---|
| CAS Number | 517-28-2 | Molecular Weight | 302.279 | |
| Density | 1.7±0.1 g/cm3 | Boiling Point | 579.9±50.0 °C at 760 mmHg | |
| Molecular Formula | C16H14O6 | Melting Point | 200 °C (dec.)(lit.) | |
| MSDS | Chinese USA | Flash Point | 304.5±30.1 °C | |
| Symbol |
GHS07 |
Signal Word | Warning | |
Use of HematoxylinHematoxylin is a natural product. |
| Name | (+)-haematoxylin |
|---|---|
| Synonym | More Synonyms |
| Description | Hematoxylin is a natural product. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.7±0.1 g/cm3 |
|---|---|
| Boiling Point | 579.9±50.0 °C at 760 mmHg |
| Melting Point | 200 °C (dec.)(lit.) |
| Molecular Formula | C16H14O6 |
| Molecular Weight | 302.279 |
| Flash Point | 304.5±30.1 °C |
| Exact Mass | 302.079041 |
| PSA | 110.38000 |
| LogP | 0.51 |
| Vapour Pressure | 0.0±1.7 mmHg at 25°C |
| Index of Refraction | 1.810 |
| InChIKey | WZUVPPKBWHMQCE-UHFFFAOYSA-N |
| SMILES | Oc1cc2c(cc1O)C1c3ccc(O)c(O)c3OCC1(O)C2 |
| Storage condition | Store at RT. |
| Stability | Stability Stable, but may discolour on exposure to light. Incompatible with strong oxidizing agents. |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302-H315-H319-H335 |
| Precautionary Statements | P301 + P312 + P330-P305 + P351 + P338 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | Xi:Irritant |
| Risk Phrases | R36/37/38 |
| Safety Phrases | 26-36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 2 |
| RTECS | MH7875000 |
| HS Code | 3302101000 |
| HS Code | 2906299090 |
|---|---|
| Summary | 2906299090 other aromatic alcohols。Supervision conditions:None。VAT:17.0%。Tax rebate rate:9.0%。MFN tariff:5.5%。General tariff:30.0% |
|
Genetic and pharmacologic inhibition of eIF4E reduces breast cancer cell migration, invasion, and metastasis.
Cancer Res. 75(6) , 1102-12, (2015) The translation initiation factor eIF4E is an oncogene that is commonly overexpressed in primary breast cancers and metastases. In this article, we report that a pharmacologic inhibitor of eIF4E funct... |
|
|
Intraplacental gene therapy with Ad-IGF-1 corrects naturally occurring rabbit model of intrauterine growth restriction.
Hum. Gene Ther. 26(3) , 172-82, (2015) Intrauterine growth restriction (IUGR) due to placental insufficiency is a leading cause of perinatal complications for which there is no effective prenatal therapy. We have previously demonstrated th... |
|
|
Itraconazole suppresses the growth of glioblastoma through induction of autophagy: involvement of abnormal cholesterol trafficking.
Autophagy 10(7) , 1241-55, (2014) Glioblastoma is one of the most aggressive human cancers with poor prognosis, and therefore a critical need exists for novel therapeutic strategies for management of glioblastoma patients. Itraconazol... |
| Hematoxylin Hydrate |
| MFCD00005394 |
| HAEMATOXYLIN(RG) |
| bematoxylin |
| Hematoxylin |
| Natural Black 1 |
| Natural Black 1 Hydrate |
| Haematoxylin |
| Homaeoxylin |
| hydroxybrazilin |
| EINECS 208-237-3 |
| h(a)ematine |